{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:49:56Z","timestamp":1791967796889,"version":"4.3.4"},"reference-count":40,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza vaccination is an effective public health intervention to lessen influenza effect on healthcare and has been recommended to prevent severe outcomes. Previous studies present higher influenza vaccine effectiveness (IVE) estimates against primary care medically attended (outpatients) compared to hospitalised cases (inpatients). Inconsistencies in study designs may hinder comparisons of IVE in preventing mild (outpatient consultations) versus severe influenza (inpatient admissions). We aimed to compare IVE against mild and severe influenza within primary care and hospital networks in Portugal from 2015\/16 to 2023\/24.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the test\u2010negative design, we analysed 3393 RT\u2010PCR\u2010tested patients with influenza\u2010like illness in outpatients or severe acute respiratory infection in inpatients. IVE was estimated using a generalised linear mixed model with fixed effects for sex, age category, comorbidities, month of symptom onset and random effects for season. For difference estimation, 95% confidence intervals (CI) were obtained through bootstrapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IVE was 40.4% (22.7; 54.0) for outpatients and 38.7% (17.6; 54.5) for inpatients. The 1.7% difference was not statistically significant (\u221222.0; 26.8). Subgroup analyses for individuals aged \u2265\u200965\u2009years, patients with comorbidities and by influenza A subtype showed similar non\u2010significant differences, ranging from \u22121% to 17%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found no statistically significant difference in IVE against mild or severe influenza infection. However, comparison across care settings should be interpreted cautiously, as patients differ in sociodemographic characteristics and comorbidity burden. Although limited sample size may reduce statistical power, the small magnitude of observed differences suggests that patients benefit from current vaccination strategies across care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/irv.70299","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:03:45Z","timestamp":1788242625000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza Vaccine Effectiveness Against Mild and Severe Outcomes: A Comparison Study in Portugal"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4757-0688","authenticated-orcid":false,"given":"Francisco","family":"Mourao","sequence":"first","affiliation":[{"name":"Escola Nacional de Sa\u00fade P\u00fablica (ENSP) Universidade Nova de Lisboa  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-0005","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA)  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-9115","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA)  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2264-4723","authenticated-orcid":false,"given":"Ana Paula","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA)  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-5874","authenticated-orcid":false,"given":"Carlos Matias","family":"Dias","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA)  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-1499","authenticated-orcid":false,"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA)  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"World Health Organization: WHO \u201cInfluenza (Seasonal) \u201d October 3 2023 (2023) https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/influenza\u2010(seasonal)."},{"key":"e_1_2_10_3_1","first-page":"E13","article-title":"Influenza Vaccination in High\u2010Risk Groups: A Revision of Existing Guidelines and Rationale for an Evidence\u2010Based Preventive Strategy","volume":"57","author":"Costantino C.","year":"2016","journal-title":"Journal of Preventive Medicine and Hygiene"},{"key":"e_1_2_10_4_1","unstructured":"Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade \u201cCampanha de Vacina\u00e7\u00e3o Sazonal do Outono\u2010Inverno 2023\u20132024 \u2013 Relat\u00f3rio final \u201d Lisboa Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade (2023)."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(11)70295\u2010X"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.18.05.20388\u2010en"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122282"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa407"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13284"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13255"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13243"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.01017"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2018.23.2.16\u201000780"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.039"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.966695"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","unstructured":"I\u2010MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly (2015) https:\/\/doi.org\/10.3030\/634446.","DOI":"10.3030\/634446"},{"key":"e_1_2_10_17_1","unstructured":"Epiconcept \u201cVaccine Effectiveness Burden and Impact Studies (VEBIS) of COVID\u201019 and Influenza \u201d Paris Epiconcept (2022) retrieved July 17 2024 https:\/\/www.epiconcept.fr\/en\/epidemio\u2010project\/vaccine\u2010effectiveness\u2010burden\u2010and\u2010impact\u2010studies\u2010vebis\u2010of\u2010covid\u201019\u2010and\u2010influenza\/2022."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.20344\/amp.13438"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050714"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww064"},{"key":"e_1_2_10_21_1","unstructured":"B.Ciancio E.Kissling A.Moren andM.Valenciano \u201cProtocol for Case\u2010Control Studies to Measure Influenza Vaccine Effectiveness in the European Union and European Economic Area Member States \u201d Stockholm European Centre for Disease Prevention and Control (2009)."},{"key":"e_1_2_10_22_1","unstructured":"T.Seyler M.Rondy M.Valenciano andA.Moren \u201cProtocol for Hospital\u2010Based Case Control Studies to Measure Seasonal Influenza Vaccine Effectiveness Against Laboratory Confirmed Influenza Hospitalisations Across the European Union and European Economic Area Member States \u201d Stockholm European Centre for Disease Prevention and Control (2014)."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13297"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5302"},{"key":"e_1_2_10_25_1","unstructured":"R Core Team \u201cR: A Language and Environment for Statistical Computing \u201d R Foundation for Statistical Computing Vienna Austria (2021)."},{"key":"e_1_2_10_26_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe (colabora\u00e7\u00e3o) \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2017\/2018 \u201d Lisboa (2017)."},{"key":"e_1_2_10_27_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe (colabora\u00e7\u00e3o) \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2018\/2019 \u201d Lisboa (2018)."},{"key":"e_1_2_10_28_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe (colabora\u00e7\u00e3o) \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2019\/2020 \u201d Lisboa (2019)."},{"key":"e_1_2_10_29_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2016\/2017 \u201d Lisbon (2016)."},{"key":"e_1_2_10_30_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Department of Epidemiology Department of Infections Diseases \u201cInfluenza Vaccine Effectiveness in Portugal. Season 2015\/2016 Report \u201d Lisbon (2015)."},{"key":"e_1_2_10_31_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade (colabora\u00e7\u00e3o) Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe e Outros V\u00edrus Respirat\u00f3rios (colabora\u00e7\u00e3o) \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2023\/2024 \u201d Lisboa (2023)."},{"key":"e_1_2_10_32_1","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) Departamento de Doen\u00e7as Infeciosas Departamento de Epidemiologia Dire\u00e7\u00e3o\u2010Geral da Sa\u00fade (colabora\u00e7\u00e3o) Rede Portuguesa de Laborat\u00f3rios para o Diagn\u00f3stico da Gripe e Outros V\u00edrus Respirat\u00f3rios (colabora\u00e7\u00e3o) \u201cPrograma Nacional de Vigil\u00e2ncia da Gripe: relat\u00f3rio da \u00e9poca 2022\/2023 \u201d Lisboa (2022)."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12714"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2018.05.004"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(16)00129\u20108"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad677"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214\u2010109X(24)00473\u2010X"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PULMOE.2022.03.005"},{"key":"e_1_2_10_39_1","unstructured":"DECRETO\u2010LEI no 96\/2020 de 4 de novembro \u201cD.R. Ia S\u00e9rie 215 (2020\u201012\u201004) 11\u201312 \u201d (n.d.)."},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1981"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv200"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.70299","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:16:18Z","timestamp":1791965778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/irv.70299"],"URL":"https:\/\/doi.org\/10.1111\/irv.70299","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2026-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70299"}}